ArticleSurgical endoscopy2025

The enhanced pathological response from additional immunotherapy improved recurrence-free survival for esophageal squamous cell carcinoma: a multi-center cohort study.

Shuhan Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.